Mesrure Köseoğlu

472 total citations
27 papers, 296 citations indexed

About

Mesrure Köseoğlu is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Mesrure Köseoğlu has authored 27 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Mesrure Köseoğlu's work include Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Mesrure Köseoğlu is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Mesrure Köseoğlu collaborates with scholars based in Türkiye, Netherlands and Italy. Mesrure Köseoğlu's co-authors include İpek Midi, Dilek İnce Günal, Müzeyyen Doğan, Günay Can, Mehmet Şehitoğlu, Serkan Özben, Marjo S. van der Knaap, Kayıhan Uluç, Nazire Afşar and Gert C. Scheper and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Neurophysiology and Journal of the Neurological Sciences.

In The Last Decade

Mesrure Köseoğlu

20 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mesrure Köseoğlu Türkiye 7 131 83 70 47 43 27 296
R. Pfeiffer United States 7 75 0.6× 36 0.4× 195 2.8× 49 1.0× 15 0.3× 17 363
Hongmei Yue China 7 189 1.4× 7 0.1× 23 0.3× 25 0.5× 44 1.0× 21 334
Doris‐Maria Denk Austria 9 150 1.1× 185 2.2× 10 0.1× 17 0.4× 6 0.1× 10 319
Ilenia Schettino Italy 7 155 1.2× 266 3.2× 129 1.8× 12 0.3× 19 0.4× 8 382
Alessandra Carta Italy 10 21 0.2× 55 0.7× 21 0.3× 166 3.5× 40 0.9× 26 538
Anthony Ghanem Lebanon 8 132 1.0× 68 0.8× 11 0.2× 6 0.1× 56 1.3× 36 249
Douglas S. Ruhl United States 11 33 0.3× 28 0.3× 35 0.5× 16 0.3× 26 0.6× 29 306
Oliver Gut Germany 3 11 0.1× 7 0.1× 7 0.1× 86 1.8× 17 0.4× 3 338
Renhe Yu China 11 38 0.3× 4 0.0× 108 1.5× 36 0.8× 50 1.2× 23 272
Gadintshware Gaoatswe Ireland 6 81 0.6× 4 0.0× 11 0.2× 86 1.8× 85 2.0× 7 408

Countries citing papers authored by Mesrure Köseoğlu

Since Specialization
Citations

This map shows the geographic impact of Mesrure Köseoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mesrure Köseoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mesrure Köseoğlu more than expected).

Fields of papers citing papers by Mesrure Köseoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mesrure Köseoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mesrure Köseoğlu. The network helps show where Mesrure Köseoğlu may publish in the future.

Co-authorship network of co-authors of Mesrure Köseoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Mesrure Köseoğlu. A scholar is included among the top collaborators of Mesrure Köseoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mesrure Köseoğlu. Mesrure Köseoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Özben, Serkan, et al.. (2025). Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise. Clinical Neurology and Neurosurgery. 250. 108785–108785.
3.
Peker, İsmail, et al.. (2024). Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis. Biomedicines. 13(1). 40–40.
4.
Boz, Cavit, Serkan Özakbaş, Murat Terzi, et al.. (2023). The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis. Neurological Sciences. 44(6). 2121–2129. 8 indexed citations
5.
Terzi, Murat, Özgül Ekmekçi, Recai Türkoğlu, et al.. (2023). Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE). TURKISH JOURNAL OF MEDICAL SCIENCES. 53(1). 323–332.
6.
Ünal, Aysun, Hüsnü Efendi, Mesrure Köseoğlu, et al.. (2023). Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting. Multiple Sclerosis and Related Disorders. 77. 104880–104880. 1 indexed citations
7.
Efendi, Hüsnü, et al.. (2022). The effect of cognitive performance on self-management behavior of multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 63. 103880–103880. 3 indexed citations
8.
Turan, Ömer Faruk, Mesrure Köseoğlu, & Emine Rabia Koç. (2022). Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy. Bursa Uludag University - AVESIS. 2. 100078–100078.
9.
Köseoğlu, Mesrure, et al.. (2020). Multipl Skleroz’de Yaşam Kalitesi: Depresif Bulgular Fiziksel Özürlülük Kadar Etkili midir?. SHILAP Revista de lepidopterología. 47(3). 712–719. 1 indexed citations
10.
Köseoğlu, Mesrure, et al.. (2020). Plasma copeptin levels in patients with multiple sclerosis. Journal of Clinical Neuroscience. 78. 143–146. 5 indexed citations
11.
Köseoğlu, Mesrure, et al.. (2020). Conversion of Optic Neuritis to Relapsing Remitting Multiple Sclerosis: A Retrospective Comorbidity Cohort Study. European Neurology. 83(3). 287–292. 2 indexed citations
12.
Köseoğlu, Mesrure, et al.. (2020). A case report with tuberculous meningitis during fingolimod treatment. Multiple Sclerosis and Related Disorders. 46. 102450–102450. 4 indexed citations
13.
14.
Bellei, Elisa, Stefania Bergamini, Emanuela Monari, et al.. (2019). Evaluation of potential cardiovascular risk protein biomarkers in high severity restless legs syndrome. Journal of Neural Transmission. 126(10). 1313–1320. 10 indexed citations
15.
Köseoğlu, Mesrure, et al.. (2017). P355 The assessment of electrophysiological studies in patients with restless legs syndrome. Clinical Neurophysiology. 128(9). e293–e294. 1 indexed citations
16.
Ceyhan, Mehmet, İnci Yıldırım, Ayşegül Neşe Çıtak Kurt, et al.. (2008). Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. Journal of Viral Hepatitis. 15(s2). 69–72. 39 indexed citations
17.
Uluç, Kayıhan, et al.. (2008). Leukoencephalopathy with brain stem and spinal cord involvement and high lactate: A genetically proven case with distinct MRI findings. Journal of the Neurological Sciences. 273(1-2). 118–122. 37 indexed citations
18.
Midi, İpek, Müzeyyen Doğan, Mesrure Köseoğlu, et al.. (2007). Voice abnormalities and their relation with motor dysfunction in Parkinson’s disease. Acta Neurologica Scandinavica. 0(0). 672054539–???. 138 indexed citations
19.
Midi, İpek, et al.. (2006). Hemichorea associated with polycythaemia vera. Neurological Sciences. 27(6). 439–441. 19 indexed citations
20.
Bolaman, Zahit, et al.. (2001). Prevalence of Beta Thalassemia Trait in Denizli.. PubMed. 18(2). 85–8. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Pfeiffer Breakdown of academic impact, for papers by Hongmei Yue Breakdown of academic impact, for papers by Doris‐Maria Denk Breakdown of academic impact, for papers by Ilenia Schettino Breakdown of academic impact, for papers by Alessandra Carta Breakdown of academic impact, for papers by Anthony Ghanem Breakdown of academic impact, for papers by Douglas S. Ruhl Breakdown of academic impact, for papers by Oliver Gut Breakdown of academic impact, for papers by Renhe Yu Breakdown of academic impact, for papers by Gadintshware Gaoatswe
Rankless by CCL
2026